United States · Bill · S
S. 1734 (103rd)
Market Exclusivity Act of 1993
Introduced
20 November 1993
Last action
3 February 1994 · Referred
Status
Referred to Subcommittee on Antitrust, Monopolies and Business.
Sponsors
Rep. Simon, Paul [D-IL-24], Sen. Hatch, Orrin G. [R-UT], Sen. Moseley-Braun, Carol [D-IL]
Subjects
Healthcare
Source updated
10 August 2026
Summary
Market Exclusivity Act of 1993 - Amends the Federal Food, Drug, and Cosmetic Act to extend the market exclusivity for a drug which meets the specified requirements of this Act.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
19 November 1993
Introduced
Sponsor introductory remarks on measure. (CR S16492)
Source: IntroReferral
20 November 1993
Introduced
Read twice and referred to the Committee on Judiciary.
Source: IntroReferral
20 November 1993
Introduced
Introduced in Senate
Source: IntroReferral
3 February 1994
Referred
Referred to Subcommittee on Antitrust, Monopolies and Business.
Source: Committee
Votes
No vote records are attached yet.
Versions
- Introduced in Senate · 20 November 1993 · Official file
Documents
3 official files
Introduced in Senate (text)
Introduced in Senate · EN · 20 November 1993
Introduced in Senate (PDF)
Introduced in Senate · EN · 20 November 1993
Introduced in Senate
summary · EN · 20 November 1993
Sponsors
- Rep. Simon, Paul [D-IL-24] · D · Sponsor
- Sen. Hatch, Orrin G. [R-UT] · R · Sponsor
- Sen. Moseley-Braun, Carol [D-IL] · D · Sponsor
- · ssju00 · Standing
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/103rd-congress/senate-bill/1734
- Open data entity: https://api.congress.gov/v3/bill/103/s/1734
- us · 103-s-1734 · source updated 10 August 2026